Related Experiment Video

Updated: Jun 22, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

New mechanisms for PRLr action in breast cancer

Charles V Clevenger1, Samantha L Gadd, Jiamao Zheng

  • 1Department of Pathology and Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA. clevenger@northwestern.edu

Trends in Endocrinology and Metabolism: TEM
|June 19, 2009
PubMed

Insights

Prolactin (PRL) hormone drives breast tissue growth via its receptor (PRLr). Understanding PRL:PRLr interactions reveals how ligand binding activates signaling, offering new breast cancer therapy targets.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cancer Research

Background:

  • Prolactin (PRL) is a hormone crucial for normal and malignant breast tissue growth.
  • PRL exerts its effects by binding to its receptor, PRLr, a member of the cytokine receptor superfamily.
  • The precise mechanisms linking PRL:PRLr interaction to downstream signaling activation remain unclear.

Purpose of the Study:

  • To review the molecular mechanisms of PRL receptor (PRLr) activation upon ligand binding.
  • To elucidate the signaling pathways initiated by the PRL:PRLr complex.
  • To explore potential therapeutic strategies targeting PRLr in breast cancer.

Main Methods:

  • Literature review focusing on PRLr signaling.
  • Analysis of evidence for PRLr predimerization.
  • Examination of the role of cyclophilin A in PRLr-Jak2 kinase activation.

Main Results:

  • PRLr undergoes ligand-induced conformational changes essential for its function.
  • Evidence suggests PRLr may predimerize even without ligand binding.
  • Cyclophilin A plays a role in the activation of PRLr-associated Jak2 kinase following ligand binding.

Conclusions:

  • Ligand binding induces necessary conformational changes in the PRLr complex.
  • Understanding these activation processes provides insights into PRLr-driven breast cancer.
  • Targeting PRLr conformational changes and associated signaling offers potential therapeutic avenues for breast cancer.

More Related Videos

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cell Signaling in Plants01:25

Cell Signaling in Plants

Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...